Daniel Gil
Venture Partner at Visionary Ventures
About
30+ year pharmaceutical R&D veteran currently serving as CEO of Pelage Pharmaceuticals. Previously led research groups at Allergan with oversight of preclinical to early clinical development, generating 13 drug candidates and authoring 42 peer-reviewed articles. Holds degrees from Harvard and University of Pennsylvania.
Colleagues at Visionary Ventures
Bill Carpou
Investor at Visionary Ventures
Bob Avery
Investor at Visionary Ventures
Dick Lindstrom
Investor at Visionary Ventures
Ehsan Sadri
Investor at Visionary Ventures
Garrett Hamontree
Partner & CFO at Visionary Ventures
Jeffry Weinhuff
Managing Partner at Visionary Ventures
Perry Sternberg
Venture Partner at Visionary Ventures
Toby Tyson
Investor at Visionary Ventures